Abstract
We have developed an in vitro model of herpes simplex virus (HSV) latency in primary neurons that mimics many aspects of HSV latency in animal models and the human disease (1–3). Using this model, we demonstrated that HSV-1 and HSV-2 establish latent infections in vitro in the same neuronal cell types that are shown to harbor latent HSV in humans (3). Latent HSV infections can be produced in neuronal cultures from ganglia of rodents and primates with similar results (3). In all cases examined, the neurotrophin, nerve growth factor (NGF), is required to maintain the latent infections. Depletion of NGF results in the reactivation of latent virus (1–3). Depending upon the conditions and the use of a high multiplicity of infection, latent HSV-1 infections are established in the majority of primary sensory or sympathetic neurons in tissue culture (2,4). To achieve high efficiency of establishment of latency with little or no evidence of lytic infection, an antiviral agent (e.g., acyclovir) is added to the neuronal cultures during the first week after inoculation with virus. However, latency can be established in the absence of antiviral treatment provided that the multiplicity of infection (MOI) is very low (1,2). At least one of the actions of the antiviral treatment is to prevent amplification of the input virus in the nonneuronal cells that are present in the culture at the outset of the infection. These nonneuronal cells are destroyed in the presence of acyclovir and virus (4). Latency is maintained in neurons in culture for as long as 10 wk in the presence of NGF. Viral transcripts and antigens associated with the productive infection are not detected during the latent infection (2,3,5). Viral transcription is restricted to the latency-associated transcripts (LAT) during the latent infection and is present in the nuclei of 80–90% of the neurons by 3 wk postinfection (4,5) Upon removal of NGF from the culture medium, for as brief as 1 h, reactivation of latent virus is induced (3), and viral antigens associated with the productive infection and infectious virus are detected between 48–72 h after NGF deprivation.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wilcox, C. L. Johnson, E. M. (1987) Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro. J. Virol. 61, 2311–2315.
Wilcox, C. L. Johnson, E. M., Jr. (1988) Characterization of nerve growth factor-dependent herpes simplex virus latency in neurons in vitro. J. Virol. 62, 393–399.
Wilcox, C. L., Smith, R. L., Freed, C., and Johnson, E. M. (1990) Nerve growth factor-dependence of herpes simplex latency in peripheral sympathetic and sensory neurons in vitro. J. Neurosci. 10, 1268–1275.
Smith, R. L., Escudero, J. L., and Wilcox, C. L. (1994) Regulation of the herpes simplex virus latency-associated transcript during establishment of latency in sensory neurons in vitro. Virology 202, 49–60.
Doerig, C., Pizer, L. I., and Wilcox, C. L. (1991) Detection of the latency-associated transcript on neuronal cultures during the latent infection with herpes simplex virus type 1. Virology 63, 423–426.
Smith, R. L., Pizer, L. I., Johnson, E. M., Jr., and Wilcox, C. L. (1992) Activation of second-messenger pathways reactivates latent herpes simplex virus in neuronal cultures. Virology 188, 311–318.
Baringer, J R. (1974) Recovery of herpes simplex virus from human sacral ganglions N Engl. J Med 291, 828–830
Smith, R. L. and Wilcox, C. L. Gene transfer into neurons towards gene therapy of neurological diseases (Lowenstein, P and Enquist, L., eds.), Wiley, Sussex, UK, in press
Sambrock, J, Fritch, E. F, and Maniatis, T (1989) Molecular Cloning A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
Fraser, N I, Block, T M, and Spivack, J G. (1992) The latency-associated transcripts of herpes simplex virus: RNA in search of a function. Virology 191, 1–8
Arthur, J., Efstathiou, S, and Simmons, A. (1993) Intranuclear foci containing low abundance herpes simplex virus latency-associated transcripts visualized by non-isotopic in situ hybridizations. J. Gen. Virol, 74, 1363–1370.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Wilcox, C.L., Smith, R.L. (1998). HSV Latency In Vitro. In: Brown, S.M., MacLean, A.R. (eds) Herpes Simplex Virus Protocols. Methods in Molecular Medicine, vol 10. Humana Press. https://doi.org/10.1385/0-89603-347-3:317
Download citation
DOI: https://doi.org/10.1385/0-89603-347-3:317
Publisher Name: Humana Press
Print ISBN: 978-0-89603-347-4
Online ISBN: 978-1-59259-594-5
eBook Packages: Springer Protocols